Pharmacology, Toxicology and Pharmaceutical Science
Pharmacokinetics
100%
Blood Clotting Factor 8 Concentrate
68%
Blood Clotting Factor 8
66%
Haemophilia A
60%
Pharmacokinetic Modeling
40%
Drug Concentration
40%
Von Willebrand Disease
40%
Von Willebrand Factor
40%
Randomized Controlled Trial
40%
Treatment Group
35%
Therapeutic Drug Monitoring
20%
Postoperative Hemorrhage
8%
Bleeding
7%
Blood Clotting Factor 8 Plus Von Willebrand Factor
5%
Medicine and Dentistry
Pharmacokinetics
40%
Blood Clotting Factor 8 Concentrate
40%
Randomized Controlled Trial
40%
Haemophilia A
40%
Treatment Group
35%
Blood Clotting Factor 8
26%
Surgical Risk
13%
Perioperative Period
8%
Postoperative Hemorrhage
8%
Neuroscience
Pharmacokinetics
80%
Blood Clotting Factor 8 Concentrate
33%
Neural Network
20%
Blood Clotting Factor 8
13%
